Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NIH confirms cut-back in Indian trials but large sponsors hope for reform

This article was originally published in Scrip

Executive Summary

In what is probably one of its more lucid responses on the scrapping of a large number of clinical studies in India, the US National Institutes of Health (NIH), the largest source of funding for medical research in the world, has said that the Indian trials were stopped mainly because of the country's evolving trial regulations.


Related Content

Industry Sponsored Trials Fall Sharply In Challenging Indian Environment


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts